Biotech

All Articles

AstraZeneca pays out CSPC $100M for preclinical heart problem medicine

.AstraZeneca has actually settled CSPC Drug Team $100 million for a preclinical heart attack medicin...

Zephyrm finds Hong Kong IPO to money period 3 cell therapy tests

.Zephyrm Bioscience is actually gusting toward the Hong Kong stock market, declaring (PDF) for an IP...

Frazier Life Sciences gathers $630M for little, mid-cap biotechs

.Frazier Lifespan Sciences has actually sourced a further $630 thousand for its fund concentrated on...

GigaGen amasses approximately $135M BARDA bucks to hammer botulism

.Antibody aficionado GigaGen, a subsidiary of Spanish biopharma Grifols, is actually ramping up its ...

GPCR agency Septerna files for IPO on toughness of preclinical records

.Septerna is about to figure out how a biotech without "any kind of relevant medical information" fa...

Kurma shuts first $154M payload for biggest biotech fund as yet

.European VC organization Kurma Partners has revealed its own most recent biotech fund, along with 1...

Prothena markets one exec while another leaves-- Chutes &amp Ladders

.Accept to this week's Chutes &amp Ladders, our summary of substantial management hirings, shootings...

Editas profit Tip Cas9 licensing liberties for $57M

.Against the background of a Cas9 patent fight that declines to perish, Editas Medication is actuall...

Ultragenyx changes genetics treatment application to dial up efficiency

.A minority of people taking Ultragenyx Pharmaceutical's Wilson ailment gene therapy UX701 have gone...

Biopharma layoff rate stabilizes in Q3: Brutal Biotech review

.As summer months heat relies on cool winds, really hopes that this year would bring widespread fiel...